Denali Therapeutics Stock Quote DNLI - Stock Price, News, Charts, Message Board, Trades

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

23.20

Bid

22.03

Ask

24.37

Volume

694

0.00 Day's Range 0.00

14.56 52 Week Range 28.35

Market Cap

3.309B

Previous Close

24.37

Open

Last Trade

23.7889

Last Trade Time

08:06:47

Financial Volume

VWAP

Average Volume (3m)

1,153,456

Shares Outstanding

142,609,036

Dividend Yield

PE Ratio

-23.93

Earnings Per Share (EPS)

-1.02

Revenue

330.53M

Net Profit

-145.22M

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates ... Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.denalitherapeutics.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Denali Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker DNLI. The last closing price for Denali Therapeutics was $24.37. Over the last year, Denali Therapeutics shares have traded in a share price range of $ 14.56 to $ 28.35.

Denali Therapeutics currently has 142,609,036 shares outstanding. The market capitalization of Denali Therapeutics is $3.48 billion. Denali Therapeutics has a price to earnings ratio (PE ratio) of -23.93.

L'Organisme canadien de réglementation des investissements permet la reprise de la négociation - IFR

L'Organisme canadien de réglementation des investissements permet la reprise de la négociation - IFR Canada NewsWire VANCOUVER, BC, le 30 oct. 2023 VANCOUVER, BC, le 30 oct. 2023...

Canadian Investment Regulatory Organization Trade Resumption - IFR

Canadian Investment Regulatory Organization Trade Resumption - IFR Canada NewsWire VANCOUVER, BC, Oct. 30, 2023 VANCOUVER, BC, Oct. 30, 2023 /CNW/ - Trading resumes in: Company: International...

IFR Announces Shares for Services Agreements

CALGARY, Alberta, Dec. 22, 2021 (GLOBE NEWSWIRE) -- International Frontier Resources Corp. (“IFR” or the “Company”) (TSXV:IFR.V) announced today that it has entered into shares for services...

IFR Extends Letter of Intent for RTO with Private Oil and Gas Company

CALGARY, Alberta , Oct. 22, 2021 (GLOBE NEWSWIRE) -- International Frontier Resources Corporation (“IFR”) (TSX-V: IFR) announced today that an extension to December 1, 2021 has been signed to a...

International Frontier Resources Closes Second and Final Tranche of Non-Brokered Private Placement

CALGARY, Alberta, July 13, 2021 (GLOBE NEWSWIRE) -- International Frontier Resources Corporation (“IFR” or the “Company”) (TSX-V: IFR) (OTCQB: IFRTF) is pleased to announce that it has closed a...

IFR Closes First Tranche of Financing

CALGARY, Alberta, June 30, 2021 (GLOBE NEWSWIRE) -- International Frontier Resources Corporation (“IFR” or the “Company”) (TSX-V: IFR) is pleased to announce that it has closed a first tranche...

IFR Completes Convertible Debenture Financing

CALGARY, Alberta, June 14, 2021 (GLOBE NEWSWIRE) -- International Frontier Resources Corporation (“IFR”) (TSX-V: IFR) is pleased to report the closing of a US$750,000 convertible debenture...

IFR Signs Letter of Intent for RTO with Private Oil and Gas Company, Announces Secured Convertible Debenture and Common Share...

CALGARY, Alberta, May 10, 2021 (GLOBE NEWSWIRE) -- International Frontier Resources Corporation (“IFR”) (TSX-V: IFR) is pleased to announce that it has entered into a non-binding Letter of...

Suspension de la négociation par l'OCRCVM - IFR

Suspension de la négociation par l'OCRCVM - IFR Canada NewsWire VANCOUVER, BC, le 6 mai 2021 VANCOUVER, BC, le 6 mai 2021 /CNW/ - L'OCRCVM a suspendu la négociation des titres...

IIROC Trading Halt - IFR

IIROC Trading Halt - IFR Canada NewsWire VANCOUVER, BC, May 6, 2021 VANCOUVER, BC, May 6, 2021 /CNW/ - The following issues have been halted by IIROC: Company: International Frontier Resources...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.58	-2.43902439024	23.78	25.24	23.5	759423	24.24210493	CS
4	2.14	10.1614434948	21.06	25.24	20.43	982710	23.02286868	CS
12	4.29	22.6864093072	18.91	25.24	17.93	1153456	21.65456383	CS
26	7.04	43.5643564356	16.16	25.24	14.56	1203084	19.94002651	CS
52	-5.1	-18.0212014134	28.3	28.35	14.56	1044638	20.18836481	CS
156	-28.18	-54.8462436746	51.38	56.8	14.56	770592	26.99723095	CS
260	1.71	7.95718939041	21.49	93.94	12.39	687973	32.19947508	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
BBLGBone Biologics Corporation	$ 3.38 (56.48%)	15.59M
RDHLRedhill Biopharma Ltd	$ 0.5669 (47.59%)	23.14M
IMRXImmuneering Corporation	$ 1.50 (32.74%)	9.89M
CDNACareDx Inc	$ 26.20 (31.07%)	22.21k
GLMDGalmed Pharmaceuticals Ltd	$ 0.3768 (22.58%)	749
ALXOALX Oncology Holdings Inc	$ 3.16 (-34.17%)	440.95k
VWEVintage Wine Estates Inc	$ 0.0348 (-32.95%)	5.03M
NCNCnoco noco Inc	$ 0.2053 (-28.47%)	1.74M
LIPOLipella Pharmaceuticals Inc	$ 0.6668 (-21.65%)	165.59k
NVANova Minerals Limited	$ 4.18 (-18.20%)	1
HUGEFSD Pharma Inc	$ 0.1218 (20.59%)	46.75M
RDHLRedhill Biopharma Ltd	$ 0.5669 (47.59%)	23.14M
BBLGBone Biologics Corporation	$ 3.38 (56.48%)	15.59M
NVDANVIDIA Corporation	$ 120.23 (2.74%)	11.72M
IMRXImmuneering Corporation	$ 1.50 (32.74%)	9.89M